Kenzie L. Preston
Affiliations: | Clinical Pharmacology and Therapeutics Research Branch - Intramural Research Program | National Institute on Drug Abuse |
Google:
"Kenzie Preston"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Finan PH, Mun CJ, Epstein DH, et al. (2019) Multimodal assessment of sleep in men and women during treatment for opioid use disorder. Drug and Alcohol Dependence. 207: 107698 |
| Kleykamp BA, De Santis M, Dworkin RH, et al. (2019) Craving and opioid use disorder: A scoping review. Drug and Alcohol Dependence. 205: 107639 |
| Bertz JW, Epstein DH, Reamer D, et al. (2019) Sleep reductions associated with illicit opioid use and clinic-hour changes during opioid agonist treatment for opioid dependence: Measurement by electronic diary and actigraphy. Journal of Substance Abuse Treatment. 106: 43-57 |
| Panlilio LV, Stull SW, Kowalczyk WJ, et al. (2019) Stress, craving and mood as predictors of early dropout from opioid agonist therapy. Drug and Alcohol Dependence. 202: 200-208 |
| Gardner RA, Epstein DH, Preston KL, et al. (2019) Defining and Predicting Opioid and Cocaine Treatment Response. Substance Use & Misuse. 1-10 |
| Holtyn AF, Bosworth E, Marsch LA, et al. (2019) Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology. Contemporary Clinical Trials Communications. 15: 100392 |
| Stull SW, Panlilio LV, Moran LM, et al. (2019) The chippers, the quitters, and the highly symptomatic: A 12-month longitudinal study of DSM-5 opioid- and cocaine-use problems in a community sample. Addictive Behaviors. 96: 183-191 |
| Spagnolo PA, Kimes A, Schwandt ML, et al. (2019) Striatal Dopamine Release in Response to Morphine: A [C]-Raclopride Positron Emission Tomography Study in Healthy Men. Biological Psychiatry |
| Crist R, Phillips K, Furnari M, et al. (2019) SA107A FUNCTIONAL OPRD1 VARIANT PREDICTS BUPRENORPHINE EFFICACY IN AFRICAN-AMERICANS WITH OPIOID USE DISORDER European Neuropsychopharmacology. 29: S1247-S1248 |
| Crist R, Zhang A, Doyle G, et al. (2019) An Oprd1 Variant Predicts Continued Opioid Use In African-Americans Undergoing Buprenorphine Treatment European Neuropsychopharmacology. 29 |